Open Access
Open access
Annual Review of Biochemistry, volume 87, issue 1, pages 451-478

Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design

Lin Jinzhong 1
Zhou Dejian 1
Steitz Thomas A. 2, 3, 4
Polikanov Yury S. 5
Gagnon Matthieu G 2, 4, 6
5
 
Department of Biological Sciences, and Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, Illinois 60607, USA;
6
 
Current affiliation: Department of Microbiology and Immunology, and Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, Texas 77555, USA;
Publication typeJournal Article
Publication date2018-06-20
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor16.6
ISSN00664154, 15454509
Biochemistry
Abstract
Genetic information is translated into proteins by the ribosome. Structural studies of the ribosome and of its complexes with factors and inhibitors have provided invaluable information on the mechanism of protein synthesis. Ribosome inhibitors are among the most successful antimicrobial drugs and constitute more than half of all medicines used to treat infections. However, bacterial infections are becoming increasingly difficult to treat because the microbes have developed resistance to the most effective antibiotics, creating a major public health care threat. This has spurred a renewed interest in structure-function studies of protein synthesis inhibitors, and in few cases, compounds have been developed into potent therapeutic agents against drug-resistant pathogens. In this review, we describe the modes of action of many ribosome-targeting antibiotics, highlight the major resistance mechanisms developed by pathogenic bacteria, and discuss recent advances in structure-assisted design of new molecules.

Citations by journals

1
2
3
4
5
6
7
8
9
Nucleic Acids Research
Nucleic Acids Research, 9, 4.66%
Nucleic Acids Research
9 publications, 4.66%
Nature Communications
Nature Communications, 7, 3.63%
Nature Communications
7 publications, 3.63%
Antibiotics
Antibiotics, 4, 2.07%
Antibiotics
4 publications, 2.07%
Molecules
Molecules, 4, 2.07%
Molecules
4 publications, 2.07%
Microorganisms
Microorganisms, 4, 2.07%
Microorganisms
4 publications, 2.07%
Nature Chemical Biology
Nature Chemical Biology, 4, 2.07%
Nature Chemical Biology
4 publications, 2.07%
mBio
mBio, 4, 2.07%
mBio
4 publications, 2.07%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 3, 1.55%
International Journal of Molecular Sciences
3 publications, 1.55%
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 3, 1.55%
Proceedings of the National Academy of Sciences of the United States of America
3 publications, 1.55%
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 2, 1.04%
Antimicrobial Agents and Chemotherapy
2 publications, 1.04%
Biochimie
Biochimie, 2, 1.04%
Biochimie
2 publications, 1.04%
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology, 2, 1.04%
Frontiers in Cellular and Infection Microbiology
2 publications, 1.04%
Cells
Cells, 2, 1.04%
Cells
2 publications, 1.04%
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology, 2, 1.04%
Frontiers in Bioengineering and Biotechnology
2 publications, 1.04%
Frontiers in Microbiology
Frontiers in Microbiology, 2, 1.04%
Frontiers in Microbiology
2 publications, 1.04%
Nature
Nature, 2, 1.04%
Nature
2 publications, 1.04%
Current Microbiology
Current Microbiology, 2, 1.04%
Current Microbiology
2 publications, 1.04%
Nature Chemistry
Nature Chemistry, 2, 1.04%
Nature Chemistry
2 publications, 1.04%
Nature Structural and Molecular Biology
Nature Structural and Molecular Biology, 2, 1.04%
Nature Structural and Molecular Biology
2 publications, 1.04%
Journal of Biological Chemistry
Journal of Biological Chemistry, 2, 1.04%
Journal of Biological Chemistry
2 publications, 1.04%
ChemMedChem
ChemMedChem, 2, 1.04%
ChemMedChem
2 publications, 1.04%
ACS Infectious Diseases
ACS Infectious Diseases, 2, 1.04%
ACS Infectious Diseases
2 publications, 1.04%
ACS Chemical Biology
ACS Chemical Biology, 2, 1.04%
ACS Chemical Biology
2 publications, 1.04%
Microbiology spectrum
Microbiology spectrum, 2, 1.04%
Microbiology spectrum
2 publications, 1.04%
Natural Product Reports
Natural Product Reports, 2, 1.04%
Natural Product Reports
2 publications, 1.04%
Critical Reviews in Microbiology
Critical Reviews in Microbiology, 2, 1.04%
Critical Reviews in Microbiology
2 publications, 1.04%
Acta Naturae, 1, 0.52%
Acta Naturae
1 publication, 0.52%
Biomolecules
Biomolecules, 1, 0.52%
Biomolecules
1 publication, 0.52%
Molecular Pharmacology
Molecular Pharmacology, 1, 0.52%
Molecular Pharmacology
1 publication, 0.52%
1
2
3
4
5
6
7
8
9

Citations by publishers

5
10
15
20
25
30
35
Springer Nature
Springer Nature, 32, 16.58%
Springer Nature
32 publications, 16.58%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 23, 11.92%
Multidisciplinary Digital Publishing Institute (MDPI)
23 publications, 11.92%
Elsevier
Elsevier, 21, 10.88%
Elsevier
21 publications, 10.88%
Oxford University Press
Oxford University Press, 12, 6.22%
Oxford University Press
12 publications, 6.22%
Wiley
Wiley, 12, 6.22%
Wiley
12 publications, 6.22%
American Society for Microbiology
American Society for Microbiology, 10, 5.18%
American Society for Microbiology
10 publications, 5.18%
Frontiers Media S.A.
Frontiers Media S.A., 8, 4.15%
Frontiers Media S.A.
8 publications, 4.15%
American Chemical Society (ACS)
American Chemical Society (ACS), 8, 4.15%
American Chemical Society (ACS)
8 publications, 4.15%
Taylor & Francis
Taylor & Francis, 5, 2.59%
Taylor & Francis
5 publications, 2.59%
Annual Reviews
Annual Reviews, 3, 1.55%
Annual Reviews
3 publications, 1.55%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 3, 1.55%
Royal Society of Chemistry (RSC)
3 publications, 1.55%
Proceedings of the National Academy of Sciences (PNAS)
Proceedings of the National Academy of Sciences (PNAS), 3, 1.55%
Proceedings of the National Academy of Sciences (PNAS)
3 publications, 1.55%
American Society for Pharmacology and Experimental Therapeutics
American Society for Pharmacology and Experimental Therapeutics, 2, 1.04%
American Society for Pharmacology and Experimental Therapeutics
2 publications, 1.04%
American Society for Biochemistry and Molecular Biology
American Society for Biochemistry and Molecular Biology, 2, 1.04%
American Society for Biochemistry and Molecular Biology
2 publications, 1.04%
Acta Naturae Ltd, 1, 0.52%
Acta Naturae Ltd
1 publication, 0.52%
Bentham Science
Bentham Science, 1, 0.52%
Bentham Science
1 publication, 0.52%
Mary Ann Liebert
Mary Ann Liebert, 1, 0.52%
Mary Ann Liebert
1 publication, 0.52%
Microbiology Society
Microbiology Society, 1, 0.52%
Microbiology Society
1 publication, 0.52%
The Royal Society
The Royal Society, 1, 0.52%
The Royal Society
1 publication, 0.52%
Future Medicine
Future Medicine, 1, 0.52%
Future Medicine
1 publication, 0.52%
Biophysical Society of Japan
Biophysical Society of Japan, 1, 0.52%
Biophysical Society of Japan
1 publication, 0.52%
PeerJ
PeerJ, 1, 0.52%
PeerJ
1 publication, 0.52%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 1, 0.52%
Public Library of Science (PLoS)
1 publication, 0.52%
Pleiades Publishing
Pleiades Publishing, 1, 0.52%
Pleiades Publishing
1 publication, 0.52%
Hindawi Limited
Hindawi Limited, 1, 0.52%
Hindawi Limited
1 publication, 0.52%
eLife Sciences Publications
eLife Sciences Publications, 1, 0.52%
eLife Sciences Publications
1 publication, 0.52%
Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory, 1, 0.52%
Cold Spring Harbor Laboratory
1 publication, 0.52%
Belgorod National Research University
Belgorod National Research University, 1, 0.52%
Belgorod National Research University
1 publication, 0.52%
Naukova Dumka, 1, 0.52%
Naukova Dumka
1 publication, 0.52%
5
10
15
20
25
30
35
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Lin J. et al. Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design // Annual Review of Biochemistry. 2018. Vol. 87. No. 1. pp. 451-478.
GOST all authors (up to 50) Copy
Lin J., Zhou D., Steitz T. A., Polikanov Y. S., Gagnon M. G. Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design // Annual Review of Biochemistry. 2018. Vol. 87. No. 1. pp. 451-478.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1146/annurev-biochem-062917-011942
UR - https://doi.org/10.1146%2Fannurev-biochem-062917-011942
TI - Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design
T2 - Annual Review of Biochemistry
AU - Lin, Jinzhong
AU - Zhou, Dejian
AU - Steitz, Thomas A.
AU - Polikanov, Yury S.
AU - Gagnon, Matthieu G
PY - 2018
DA - 2018/06/20 00:00:00
PB - Annual Reviews
SP - 451-478
IS - 1
VL - 87
SN - 0066-4154
SN - 1545-4509
ER -
BibTex |
Cite this
BibTex Copy
@article{2018_Lin,
author = {Jinzhong Lin and Dejian Zhou and Thomas A. Steitz and Yury S. Polikanov and Matthieu G Gagnon},
title = {Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design},
journal = {Annual Review of Biochemistry},
year = {2018},
volume = {87},
publisher = {Annual Reviews},
month = {jun},
url = {https://doi.org/10.1146%2Fannurev-biochem-062917-011942},
number = {1},
pages = {451--478},
doi = {10.1146/annurev-biochem-062917-011942}
}
MLA
Cite this
MLA Copy
Lin, Jinzhong, et al. “Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design.” Annual Review of Biochemistry, vol. 87, no. 1, Jun. 2018, pp. 451-478. https://doi.org/10.1146%2Fannurev-biochem-062917-011942.
Found error?